Enhancing the insights of the Patient‐and care‐related benefits of amyloid PET imaging ‐ ENABLE ‐ st...
Enhancing the insights of the Patient‐and care‐related benefits of amyloid PET imaging ‐ ENABLE ‐ study through a process evaluation: a study protocol
About this item
Full title
Author / Creator
Publisher
Hoboken: John Wiley and Sons Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken: John Wiley and Sons Inc
Subjects
More information
Scope and Contents
Contents
Background
Amyloid PET imaging is an established diagnostic tool for Alzheimer’s disease, but its successful integration into clinical practice requires a comprehensive understanding of its impact on patients and the healthcare system. In 2022, the coverage with evidence development (CED) ENABLE study has been approved by the German Federal Join...
Alternative Titles
Full title
Enhancing the insights of the Patient‐and care‐related benefits of amyloid PET imaging ‐ ENABLE ‐ study through a process evaluation: a study protocol
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11713179
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11713179
Other Identifiers
ISSN
1552-5260
E-ISSN
1552-5279
DOI
10.1002/alz.093719
